Obesity Research Today is a free monthly online journal that collates and summarizes the latest research about Obesity, including details on health, diet, prevention, exercise.

Volume 2 (2005), Issue 6 (June)

1. Dose-linear pharmacokinetics, tissue distribution, and excretion of a recombinant fusion protein 125I-GST-TatdMt possessing potent anti-obesity activity.
   Regul Pept, 129(1): 25-30. [Abstract] [Full-text]
2. Effects of insulin on left ventricular function during dynamic exercise in overweight and obese subjects.
   Eur Heart J, 26(12): 1205-12. [Abstract] [Full-text]
3. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
   Metabolism, 54(6): 800-8. [Abstract] [Full-text]
4. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
   Metabolism, 54(6): 705-12. [Abstract] [Full-text]
5. Low salt intake modulates insulin signaling, JNK activity and IRS-1ser307 phosphorylation in rat tissues.
   J Endocrinol, 185(3): 429-37. [Abstract] [Full-text]
6. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.
   Am J Gastroenterol, 100(6): 1243-50. [Abstract] [Full-text]
7. Molecular breakpoint cloning and gene expression studies of a novel translocation t(4;15)(q27;q11.2) associated with Prader-Willi syndrome.
   BMC Med Genet, 6: 18. [Abstract] [Full-text]
8. Bioactive food stimulants of sympathetic activity: effect on 24-h energy expenditure and fat oxidation.
   Eur J Clin Nutr, 59(6): 733-41. [Abstract] [Full-text]
9. Application of obesity treatment algorithms to Canadian adults.
   Eur J Clin Nutr, 59(6): 797-800. [Abstract] [Full-text]
10. Is it feasible to reach the bypassed stomach after Roux-en-Y gastric bypass for morbid obesity? The use of the double-balloon enteroscope.
    Endoscopy, 37(6): 566-9. [Abstract] [Full-text]
11. Is laparoscopic colectomy applicable to patients with body mass index >30? A case-matched comparative study with open colectomy.
    Dis Colon Rectum, 48(5): 975-81. [Abstract] [Full-text]
12. Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy.
    J Physiol, 565: 463-74. [Abstract] [Full-text]
13. Obesity before age 30 years and risk of advanced prostate cancer.
    Am J Epidemiol, 161(12): 1107-14. [Abstract] [Full-text]
14. Treatment with a dietary fat substitute decreased Arochlor 1254 contamination in an obese diabetic male.
    J Nutr Biochem, 16(6): 383-4. [Abstract] [Full-text]
15. The association between obesity and the frailty syndrome in older women: the Women's Health and Aging Studies.
    J Am Geriatr Soc, 53(6): 927-34. [Abstract] [Full-text]
16. Up-regulation of the expression of cocaine and amphetamine-regulated transcript peptide by electroacupuncture in the arcuate nucleus of diet-induced obese rats.
    Neurosci Lett, 383(1): 17-21. [Abstract] [Full-text]
17. An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension.
    Int J Cardiol, 102(1): 111-6. [Abstract] [Full-text]
18. Medications as adjunct therapy for weight loss: approved and off-label agents in use.
    J Am Diet Assoc, 105(6): 948-59. [Abstract] [Full-text]
19. Breakfast consumption by African-American and white adolescent girls correlates positively with calcium and fiber intake and negatively with body mass index.
    J Am Diet Assoc, 105(6): 938-45. [Abstract] [Full-text]
20. Size acceptance and intuitive eating improve health for obese, female chronic dieters.
    J Am Diet Assoc, 105(6): 929-36. [Abstract] [Full-text]
21. Behavioral consequences of testing for obesity risk.
    Cancer Epidemiol Biomarkers Prev, 14(6): 1485-9. [Abstract] [Full-text]
22. Mutation analysis of the MCHR1 gene in human obesity.
    Eur J Endocrinol, 152(6): 851-62. [Abstract] [Full-text]
23. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression.
    Cancer, 103(12): 2643-53. [Abstract] [Full-text]
24. Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure.
    Clin Auton Res, 15(3): 200-6. [Abstract] [Full-text]
25. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
    Acta Diabetol, 42(2): 104-9. [Abstract] [Full-text]
26. Chronic stress and comfort foods: self-medication and abdominal obesity.
    Brain Behav Immun, 19(4): 275-80. [Abstract] [Full-text]
27. Exaggerated feeding response to central galanin-like peptide administration in diet-induced obese rats.
    Neuropeptides, 39(3): 333-6. [Abstract] [Full-text]
28. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial.
    Aust N Z J Psychiatry, 39(6): 479-86. [Abstract] [Full-text]
29. Comparative impact of morbid obesity vs heart failure on cardiorespiratory fitness.
    Chest, 127(6): 2197-203. [Abstract] [Full-text]
30. The effect of body mass index on patient outcomes in a medical ICU.
    Chest, 127(6): 2125-31. [Abstract] [Full-text]
31. Drain erosion and gastro-jejunal fistula after one-anastomosis gastric bypass: endoscopic occlusion by fibrin sealant.
    Obes Surg, 15(5): 719-22. [Abstract] [Full-text]
32. Tachyarrhythmia due to atrial fibrillation in an intragastric balloon carrier: coincidence or consequence?
    Obes Surg, 15(5): 716-8. [Abstract] [Full-text]
33. Obesity and symptomatic achalasia.
    Obes Surg, 15(5): 713-5. [Abstract] [Full-text]
34. Complete regression of Barrett's esophagus after Roux-en-Y gastric bypass.
    Obes Surg, 15(5): 710-2. [Abstract] [Full-text]
35. Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bypass.
    Obes Surg, 15(5): 707-9. [Abstract] [Full-text]
36. Intestinal malrotation in a patient undergoing laparoscopic gastric bypass.
    Obes Surg, 15(5): 703-6. [Abstract] [Full-text]
37. "Right-angled" stapled latero-lateral duodenojejunal anastomosis in the duodenal switch.
    Obes Surg, 15(5): 700-2. [Abstract] [Full-text]
38. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin.
    Obes Surg, 15(5): 692-9. [Abstract] [Full-text]
39. The influence of eating behavior and eating pathology on weight loss after gastric restriction operations.
    Obes Surg, 15(5): 684-91. [Abstract] [Full-text]
40. Psychiatric symptoms among prospective bariatric surgery patients: rates of prevalence and their relation to social desirability, pursuit of surgery, and follow-up attendance.
    Obes Surg, 15(5): 677-83. [Abstract] [Full-text]
41. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.
    Obes Surg, 15(5): 670-6. [Abstract] [Full-text]
42. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass.
    Obes Surg, 15(5): 661-9. [Abstract] [Full-text]
43. Impedance cardiography: noninvasive assessment of hemodynamics and thoracic fluid content during bariatric surgery.
    Obes Surg, 15(5): 655-8; discussion 659-60. [Abstract] [Full-text]
44. Short-term results of laparoscopic mini-gastric bypass.
    Obes Surg, 15(5): 648-54. [Abstract] [Full-text]
45. Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year.
    Obes Surg, 15(5): 641-7. [Abstract] [Full-text]
46. Clinical and radiological follow-up of laparoscopic adjustable gastric bands, 1998 and 2000: a comparison of two techniques.
    Obes Surg, 15(5): 634-40. [Abstract] [Full-text]
47. Results of lap rebanding procedures after Lap-Band removal for band erosion -- a mid-term evaluation.
    Obes Surg, 15(5): 630-3. [Abstract] [Full-text]
48. Permeability of the silicone membrane in laparoscopic adjustable gastric bands has important clinical implications.
    Obes Surg, 15(5): 624-9. [Abstract] [Full-text]
49. Association of super-super-obesity and male gender with elevated mortality in patients undergoing the duodenal switch procedure.
    Obes Surg, 15(5): 618-23. [Abstract] [Full-text]
50. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50).
    Obes Surg, 15(5): 612-7. [Abstract] [Full-text]
51. Radiological diagnosis of internal hernia after Roux-en-Y gastric bypass.
    Obes Surg, 15(5): 606-11. [Abstract] [Full-text]
52. Evidence-based medicine reports on obesity surgery: a critique.
    Int J Obes (Lond), 29(7): 735-45. [Abstract] [Full-text]
53. Obesity in 70-year-old Swedes: secular changes over 30 years.
    Int J Obes (Lond), 29(7): 810-7. [Abstract] [Full-text]
54. Gender variations of body composition, muscle strength and power output in morbid obesity.
    Int J Obes (Lond), 29(7): 833-41. [Abstract] [Full-text]
55. Lack of association between polymorphism of the human cyclic GMP-dependent protein kinase gene and obesity.
    Int J Obes (Lond), 29(7): 872-4. [Abstract] [Full-text]
56. Do centrally obese Chinese with normal BMI have increased risk of metabolic disorders?
    Int J Obes (Lond), 29(7): 818-25. [Abstract] [Full-text]
57. Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study.
    Int J Obes (Lond), 29(7): 746-54. [Abstract] [Full-text]
58. History of weight and obesity through life and risk of benign prostatic hyperplasia.
    Int J Obes (Lond), 29(7): 798-803. [Abstract] [Full-text]
59. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.
    Int J Obes (Lond), 29(7): 766-71. [Abstract] [Full-text]
60. Categorical strategies based on subject characteristics of dietary restraint and physical activity, for weight maintenance.
    Int J Obes (Lond), 29(7): 849-57. [Abstract] [Full-text]
61. Impact of total and central obesity on vascular mortality in patients undergoing coronary angiography.
    Int J Obes (Lond), 29(7): 785-91. [Abstract] [Full-text]
62. Body composition and fat repartition in relation to structure and function of large arteries in middle-aged adults (the SU.VI.MAX study).
    Int J Obes (Lond), 29(7): 826-32. [Abstract] [Full-text]
63. The obesity epidemic in young men is not confined to low social classes--a time series of 18-year-old German men at medical examination for military service with different educational attainment.
    Int J Obes (Lond), 29(7): 875-7. [Abstract] [Full-text]
64. Early life risk factors for obesity in childhood: cohort study.
    BMJ, 330(7504): 1357. [Abstract] [Full-text]
65. Adult socioeconomic, educational, social, and psychological outcomes of childhood obesity: a national birth cohort study.
    BMJ, 330(7504): 1354. [Abstract] [Full-text]
66. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.
    BMJ, 330(7504): 1360. [Abstract] [Full-text]
67. The Third International Symposium on Obesity and Hypertension ISOH'03: 'Genetics and Molecular Mechanisms' (October 23-25, 2003, Berlin Germany).
    Int J Obes (Lond), 29(7): 727-34. [Abstract] [Full-text]
68. Is there a causal relation between obesity and asthma? Evidence from Chile.
    Int J Obes (Lond), 29(7): 804-9. [Abstract] [Full-text]
69. Antiobesity effect of a melanin-concentrating hormone 1 receptor antagonist in diet-induced obese mice.
    Endocrinology, 146(7): 3080-6. [Abstract] [Full-text]
70. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).
    Int J Obes (Lond), 29(7): 755-9. [Abstract] [Full-text]
71. Obesity-related correlation between C-reactive protein and the calculated 10-y Framingham Coronary Heart Disease Risk Score.
    Int J Obes (Lond), 29(7): 772-7. [Abstract] [Full-text]
72. Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity.
    Horm Metab Res, 37(4): 242-5. [Abstract] [Full-text]
73. Obesity and cortisol status.
    Horm Metab Res, 37(4): 193-7. [Abstract] [Full-text]
74. Prevalence of left ventricular diastolic dysfunction in obese persons with and without diabetes mellitus.
    Am J Cardiol, 95(12): 1527-8. [Abstract] [Full-text]
75. Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging.
    Am J Cardiol, 95(12): 1521-4. [Abstract] [Full-text]
76. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects.
    Arch Med Res, 36(4): 362-6. [Abstract] [Full-text]
77. Perigestational suppression of weight gain with central leptin gene therapy results in lower weight F1 generation.
    Peptides, 26(7): 1176-87. [Abstract] [Full-text]
78. Obesity and prostate cancer screening in the USA.
    Public Health, 119(8): 694-8. [Abstract] [Full-text]
79. Determination of smoking and obesity as periodontitis risks using the classification and regression tree method.
    J Periodontol, 76(6): 923-8. [Abstract] [Full-text]
80. Phenotypic profile of SWR/J and A/J mice compared to control strains: possible mechanisms underlying resistance to obesity on a high-fat diet.
    Brain Res, 1047(2): 137-47. [Abstract] [Full-text]
81. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    JAMA, 293(23): 2873-83. [Abstract] [Full-text]
82. Undertreatment of obese women receiving breast cancer chemotherapy.
    Arch Intern Med, 165(11): 1267-73. [Abstract] [Full-text]
83. Gene-diet interaction in relation to the prevention of obesity and type 2 diabetes: evidence from the Finnish Diabetes Prevention Study.
    Nutr Metab Cardiovasc Dis, 15(3): 225-33. [Abstract] [Full-text]
84. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Nutr Metab Cardiovasc Dis, 15(3): 204-11. [Abstract] [Full-text]
85. Laparoscopic gastric banding and body composition in morbid obesity.
    Nutr Metab Cardiovasc Dis, 15(3): 198-203. [Abstract] [Full-text]
86. Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight.
    Nutr Metab Cardiovasc Dis, 15(3): 181-7. [Abstract] [Full-text]
87. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.
    Diabetes Res Clin Pract, 69(1): 29-35. [Abstract] [Full-text]
88. Smoking habits and obesity in young adults.
    Addiction, 100(7): 1021-5. [Abstract] [Full-text]
89. Panniculectomy in gynecologic cancer surgical procedures by using a harmonic scalpel.
    Acta Obstet Gynecol Scand, 84(7): 690-4. [Abstract] [Full-text]
90. AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity.
    Am J Physiol Regul Integr Comp Physiol, 289(1): R181-6. [Abstract] [Full-text]
91. Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms.
    Am J Physiol Regul Integr Comp Physiol, 289(1): R117-24. [Abstract] [Full-text]
92. Obesity and risk of nonfatal unintentional injuries.
    Am J Prev Med, 29(1): 41-5. [Abstract] [Full-text]
93. Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats.
    Diabetologia, 48(6): 1075-83. [Abstract] [Full-text]
94. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.
    Am J Physiol Endocrinol Metab, 289(1): E113-22. [Abstract] [Full-text]
95. Novel paternally expressed intergenic transcripts at the mouse Prader-Willi/Angelman Syndrome locus.
    Mamm Genome, 16(4): 219-27. [Abstract] [Full-text]
96. Risk factors for post-operative mortality in bariatric surgery.
    J Surg Res, 127(1): 1-7. [Abstract] [Full-text]
97. Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.
    Int J Clin Pract, 59(7): 746-50. [Abstract] [Full-text]
98. The adipose organ.
    Prostaglandins Leukot Essent Fatty Acids, 73(1): 9-15. [Abstract] [Full-text]
99. Development of body weight in the Norwegian population.
    Prostaglandins Leukot Essent Fatty Acids, 73(1): 3-7. [Abstract] [Full-text]
100. Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study.
     Hum Genet, 117(2): 107-18. [Abstract] [Full-text]
101. Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X.
     J Pharmacol Exp Ther, 314(1): 422-30. [Abstract] [Full-text]
102. Obesity and endothelial dysfunction.
     Semin Vasc Med, 5(1): 56-64. [Abstract] [Full-text]
103. Visceral fat as a determinant of fibrinolysis and hemostasis.
     Semin Vasc Med, 5(1): 48-55. [Abstract] [Full-text]
104. The role of dietary fat in obesity.
     Semin Vasc Med, 5(1): 40-7. [Abstract] [Full-text]
105. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction.
     Semin Vasc Med, 5(1): 25-33. [Abstract] [Full-text]
106. Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions.
     Semin Vasc Med, 5(1): 15-24. [Abstract] [Full-text]
107. Epidemiology of obesity.
     Semin Vasc Med, 5(1): 3-14. [Abstract] [Full-text]
108. You are what you eat.
     Surv Ophthalmol, 50(4): 389-93. [Abstract] [Full-text]
109. Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: the Hisayama study.
     J Periodontal Res, 40(4): 346-53. [Abstract] [Full-text]
110. Fetal and perinatal programming of appetite.
     Clin Sci (Lond), 109(1): 1-11. [Abstract] [Full-text]
111. Early carotid atherosclerosis in overweight non-diabetic individuals is associated with subclinical chronic inflammation independent of underlying insulin resistance.
     Horm Metab Res, 37(5): 331-5. [Abstract] [Full-text]
112. Soy protein influences the development of the metabolic syndrome in male obese ZDFxSHHF rats.
     Horm Metab Res, 37(5): 316-25. [Abstract] [Full-text]
113. Overweight and obese in gestational diabetes: the impact on pregnancy outcome.
     Am J Obstet Gynecol, 192(6): 1768-76. [Abstract] [Full-text]
114. Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1.
     J Hum Hypertens, 19(7): 543-50. [Abstract] [Full-text]
115. Newly discovered endocrine functions of white adipose tissue: possible relevance in obesity-related diseases.
     Cell Mol Life Sci, 62(12): 1359-62. [Abstract] [Full-text]
116. Is being overweight associated with behavioural problems in childhood and adolescence? Findings from the Mater-University study of pregnancy and its outcomes.
     Arch Dis Child, 90(7): 692-7. [Abstract] [Full-text]
117. Leptin is independently associated with systolic blood pressure, pulse pressure and arterial compliance in hypertensive African women with increased adiposity: the POWIRS study.
     J Hum Hypertens, 19(7): 535-41. [Abstract] [Full-text]
118. Prevalence of overweight in children with developmental disorders in the continuous national health and nutrition examination survey (NHANES) 1999-2002.
     J Pediatr, 146(6): 738-43. [Abstract] [Full-text]
119. Steatosis: co-factor in other liver diseases.
     Hepatology, 42(1): 5-13. [Abstract] [Full-text]
120. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system.
     Clin Chem, 51(7): 1102-9. [Abstract] [Full-text]
121. Medication associated with weight gain may influence outcome in a weight management program.
     Ann Pharmacother, 39(7): 1204-8. [Abstract] [Full-text]
122. Differences in behavioural phenotype between parental deletion and maternal uniparental disomy in Prader-Willi syndrome: an ERP study.
     Clin Neurophysiol, 116(6): 1464-70. [Abstract] [Full-text]
123. National variations in morbid obesity and bariatric surgery use.
     J Am Coll Surg, 201(1): 77-84. [Abstract] [Full-text]
124. Results of biliopancreatic diversion in two patients with Prader-Willi syndrome.
     Obes Surg, 15(6): 901-4. [Abstract] [Full-text]
125. Laparoscopic bariatric surgery in super-obese patients (BMI>50) is safe and effective: a review of 332 patients.
     Obes Surg, 15(6): 858-63. [Abstract] [Full-text]
126. One-year changes in energy expenditure and serum leptin following adjustable gastric banding in obese women.
     Obes Surg, 15(6): 827-33. [Abstract] [Full-text]
127. Tissue oxygenation in obese and non-obese patients during laparoscopy.
     Obes Surg, 15(6): 813-9. [Abstract] [Full-text]
128. Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty.
     Obes Surg, 15(6): 803-8. [Abstract] [Full-text]
129. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery.
     Obes Surg, 15(6): 788-93. [Abstract] [Full-text]
130. Obesity-related differential gene expression in the visceral adipose tissue.
     Obes Surg, 15(6): 758-65. [Abstract] [Full-text]
131. Obesity enhances the induction of plasminogen activator inhibitor-1 by restraint stress: a possible mechanism of stress-induced renal fibrin deposition in obese mice.
     J Thromb Haemost, 3(7): 1495-502. [Abstract] [Full-text]
132. Calcium deficiency cannot induce obesity in rats.
     Physiol Behav, 85(3): 259-64. [Abstract] [Full-text]
133. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
     Basic Res Cardiol, 100(4): 346-54. [Abstract] [Full-text]
134. Disorders of fuel metabolism: medical complications associated with starvation, eating disorders, dietary fads, and supplements.
     Emerg Med Clin North Am, 23(3): 789-813, ix. [Abstract] [Full-text]
135. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity.
     Mol Cell Endocrinol, 239(1): 1-14. [Abstract] [Full-text]
136. Maladaptive behaviors and risk factors among the genetic subtypes of Prader-Willi syndrome.
     Am J Med Genet A, 136(2): 140-5. [Abstract] [Full-text]
137. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment.
     Am J Med Genet A, 136(1): 45-8. [Abstract] [Full-text]
138. Perception of overweight and obesity among Portuguese adolescents: an overview of associated factors.
     Eur J Public Health, 15(3): 323-8. [Abstract] [Full-text]
139. Impaired response of cardiac autonomic nervous system to glucose load in severe obesity.
     Metabolism, 54(7): 966-74. [Abstract] [Full-text]
140. Modest weight loss improves insulin action in obese African Americans.
     Metabolism, 54(7): 960-5. [Abstract] [Full-text]
141. Restoration of the jawline and the neck after bariatric surgery.
     Facial Plast Surg, 21(1): 28-32. [Abstract] [Full-text]

© 2004-2008 Obesity Research Today. All Rights Reserved.